Terms: = Lymphoma AND FLI1, SIC-1, 2313, ENSG00000151702, Q01543, EWSR2 AND Prognosis
4 results:
1. Transcription factor Fli-1 as a new target for antitumor drug development.
Li L; Yu J; Cheng S; Peng Z; Luo H
Int J Biol Macromol; 2022 Jun; 209(Pt A):1155-1168. PubMed ID: 35447268
[TBL] [Abstract] [Full Text] [Related]
2. Cryptic TCF3 fusions in childhood leukemia: Detection by RNA sequencing.
Salim M; Heldt F; Thomay K; Lentes J; Behrens YL; Kaune B; Möricke A; Cario G; Schieck M; Hofmann W; Davenport C; Steinemann D; Schrappe M; Schlegelberger B; Göhring G
Genes Chromosomes Cancer; 2022 Jan; 61(1):22-26. PubMed ID: 34460133
[TBL] [Abstract] [Full Text] [Related]
3. Potent Anti-leukemia Activities of Chimeric Antigen Receptor-Modified T Cells against CD19 in Chinese Patients with Relapsed/Refractory Acute Lymphocytic Leukemia.
Hu Y; Wu Z; Luo Y; Shi J; Yu J; Pu C; Liang Z; Wei G; Cui Q; Sun J; Jiang J; Xie J; Tan Y; Ni W; Tu J; Wang J; Jin A; Zhang H; Cai Z; Xiao L; Huang H
Clin Cancer Res; 2017 Jul; 23(13):3297-3306. PubMed ID: 28039267
[No Abstract] [Full Text] [Related]
4. Superficial Ewing's sarcoma family of tumors: a clinicopathological study with differential diagnoses.
Machado I; Llombart B; Calabuig-Fariñas S; Llombart-Bosch A
J Cutan Pathol; 2011 Aug; 38(8):636-43. PubMed ID: 21649689
[TBL] [Abstract] [Full Text] [Related]
